In the Matter of Hoechst Marion Roussel, Inc., a corporation, Carderm Capital L.P., a limited partnership, and Andrx Corporation, a corporation.

Docket No. 9293

April 4, 2001

• Agreement Containing Consent Order [PDF 1.9MB]

March 28, 2001

• Notice of Apearance (James M. Spears) [PDF]

November 28, 2000

• Order Withdrawing Matter From Adjudication [PDF]
• Joint Motion to Withdraw Matter From Adjudication [PDF]

November 27, 2000

• Order Amending Second Scheduling Order [PDF]

November 22, 2000

• Order on Respondents' Application For In Camera Treatment of Certain Documents [PDF]
• Respondent Hoechst Marion Roussel, Inc.'s Memorandum in Opposition to Complaint Counsel's Motion to Stay or Modify Order to Destroy Inadvertently Disclosed Material [PDF]
• Respondent Andrx Corporation's Opposition to Complaint Counsel's Motion to Compel Admissions [PDF]

November 21, 2000

• Order Granting Andrx's Request for Certification to the Commission For Enforcement of Subpoenas [PDF]
• Complaint Counsel's Opposition to Respondent Hoechst Marion Roussel, Inc.'s Motion to Compel Interrogatory Responses [PDF]
• Motion of Non-Party Novartis Corporation for In Camera Treatment of Certain Documents [PDF]

November 17, 2000

• Respondent Hoechst Marion Roussel, Inc.'s Motion In Limine To Exclude Evidence or Argument That The Stipulation and Agreement is Illegal Per Se [PDF]
• Respondent Hoechst Marion Roussel, Inc.'s First Amended Objections and Responses to Complaint Counsel's First Request for Admissions [PDF]
• Respondent Andrx Corporation's Motion to Compel Deposition Testmony of David A. Balto [PDF]
• Respondent Andrx's Motion to Preclude Complaint Counsel from Introducing Evidence of Certain Conversations Between Respondents and FTC Staff Members [PDF]
• Respondent Andrx's Motion to Conditionally Preclude, Certify and/or Keep the Hearing Open Pending Further Discovery Regarding Affirmative Defenses [PDF]
• Respondent Hoechst Marion Roussel, Inc.'s Motion In Limine to Limit the Testimony of Professor Richard Frank [PDF]
• Respondent Hoechst Marion Roussel, Inc.'s Motion In Limine to Exclude References to Settlement Discussions [PDF]

November 16, 2000

• Motion In Limine to Preclude Selected Testimony by Scott Lodin [PDF]
• Motion In Limine to Preclude Selected Testimony by Edward Stratemeier [PDF]
• Stipulation [PDF]
• Complaint Counsel's Motion In Limine to Preclude Respondents' Introduction of Evidence Offered to Show Patent Infringment [PDF]

November 15, 2000

• Complaint Counsel's Motion Motion for Official Notice [PDF]
• Complaint Counsel's Motion to Stay or Modify Order to Destroy Inadvertently Disclosed Material [PDF]

November 14, 2000

• Hoechst Marion Roussel, Inc.'s Motion to Compel Response to Interrogatory Nos. 1, 11 and 16 [PDF]

November 13, 2000

• Complaint Counsel's Motion to Compel Admissions by Hoechst Marion Roussel, Inc.'s in Response to Complaint Counsel's First Request for Admissions [PDF]
• Order Granting Joint Motion to Modify Scheduling Order [PDF]
• Second Amended Scheduling Order [PDF]
• Notice of Apearance (Stacey L. Ehrlich) [PDF]

November 9, 2000

• Joint Motion Regarding Modification to Scheduling Order [PDF]

November 8, 2000

• Order Denting Andrx's Motion to Compel Deposition Testimony of FTC Staff Members [PDF]
• Order Granting Joint Motion for Leave to File Motions to Compel Certain Discovery [PDF]
• Complaint Counsel's Motion to Compel Admissions by Andrx Corporation in Response to Complaint Counsel's First Request for Admissions [PDF]
• Order on Andrx Motion to Compel Melnyk and Brydon to Appear for Depositions and Produce Documents [PDF]
• Joint Motion for Leave to File Motions to Compel Certain Discovery [PDF]

November 6, 2000

• Motion of Respondent Andrx Corporation for Leave to File Annexed "Supplemental Submission in Further Support of Motion to Compel Deposition Testimony or to Preclude" [PDF]

• Notice of Apearance (Richard A. Feinstein) [PDF]

November 1, 2000

• Respondent Andrx Corporation's Notice of Noncompliance with Third-Party Subpoenae Served on Biovail Law Firms [PDF]

October 31, 2000

• Order Denying Aventis' Motion to Compel Production of Documents from Complaint Counsel [PDF]
• Order on Andrx's Motion to Compel Complaint Counsel to Provide Limited Deposittion Discovery Relating to Affirmative Defenses [PDF]

October 26, 2000

• Notice of Apearance (Louis M. Solomon) [PDF]
• Memorandum in Opposition to Andrx Corporation's Motion to Compel the Depositions of Non-Parties Eugene N. Melnyk and Bruce Brydon and the Production of Documents [PDF]
• Order on Barr Laboratories, Inc.'s Motion to Quash [PDF]
• Order on Aetna's Motion for a Protective Order and Aventis' Motion to Enforce Subpoena on Aetna [PDF]

October 25, 2000

• Order Denying Motion for Interlocutory Appeal [PDF]
• Respondent Andrx's Motion to Compel Deposition Testimony or to Preclude [PDF]
• Omnibus Motion of Non-Party Novartis Corporation for in Camera Treatment of Certain Documents [PDF]

October 24, 2000

• Complaint Counsel's Opposition to Respondent Andrx's Motion to Compel Eugene N. Melnyk and Bruce Brydon to Appear for Depositions or, in the Alternative, to Preclude Biovail Witnesses from Appearing at Trial [PDF]
• Order Denying Aventis' Motion to Enforce Compliance with the Subpoena Served on Alpharma [PDF]

October 23, 2000

• Order Denying Aventis' Motion to Enforce Compliance with the Subpoena Served on Sitrick [PDF]
• Order on Aventis' Motion to Withdraw its Motion to Enforce Compliance with the Subpoena Served on Zenith [PDF]

October 19, 2000

• Amended Scheduling Order [PDF]
• Aventis Pharmaceuticals, Inc.'s Motion to Withdraw its Motion to Enforce Compliance with the Subpoena Served on Zenith Goldline Pharmaceuticals, Inc. [PDF]
• Respondent Hoechst Marion Roussel, Inc.'s Objections and Responses to Complaint Counsel's First Request for Admissions [PDF]

October 17, 2000

• Complaint Counsel's Memorandum in Opposition to Andrx's Motion to Compel Depositions of Jex, Ingelfield, and Balto [PDF]
• Order Denying Complaint Counsel's Motion Regarding Hoechst's Waiver of Attorney-Client Privilege and Motion to Compel Answers to Deposition Questions [PDF]
• Respondent Andrx Corporation's Memorandum in Opposition to Joint Motion for Interlocutory Appeal [PDF]
• Respondent Andrx Corporation's Motion to Compel Eugene N. Melnyk and Bruce Brydon to Appear for Depositions and Produce Documents [PDF]

October 16, 2000

• Notice of Apearance (Michael L. Koon) [PDF]
• Complaint Counsel's Opposition to Aventis's Motion to Compel [PDF]Strick and Company's Answer to Aventis Pharmaceuticals, Inc.'s ("Hoechst's") Motion to Enforce Complaince with the Subpoena Served on Strick and Company [PDF]

October 13, 2000

• Barr Laboratories, Inc.'s Motion to Quash Non-Party Subpoenas Issued by Andrx Corporation [PDF]
• Joint Motion for Interlocutory Appeal [PDF]
• Alpharma, Inc.'s Opposition to Aventis Pharmaceuticals, Inc.'s Motion to Enforce Complaince with the Subpoena Served on Alpharma, Inc. [PDF]

October 12, 2000

• Order Denying Respondents' Motion for Protective Orders [PDF]

October 11, 2000

• Respondent Aventis Pharmaceuticals, Inc.'s Memorandum in Opposition to Complaint Counsel's Motion Regarding Waiver of Privilege [PDF]
• Order on Elan Pharmaceuticals, Inc.'s Motion to Quash [PDF]
• Respondent Andrx Corporation's Motion to Compel Complaint Counsel to Provide Limited Deposition Discovery Relating to Affirmative Defenses [PDF]

October 10, 2000

• Complaint Counsel's Opposition to Respondents'Applications for In Camera Protection of Certain of its Confidential Materials [PDF]
• Non-Party Aetna U.S. Healthcare, Inc's Request that this Court Enter its Motion for a Protective Order Given Respondent Aventis' Lack of Opposition [PDF]

October 6, 2000

• Merk-Medco Mananged Care L.L.C.'s Motion for In Camera Treatment [PDF]
• Merk & Co., Inc's Motion for In Camera Treatment [PDF]

October 5, 2000

• Aventis Pharmaceuticals, Inc.'s Motion for Leave to Respond to Non-Party Witness Aetna U.S. Healthcare, Inc's Memorandum in Opposition to Adventis Pharmaceuticals, Inc's Motion to Enforce Compliance with the Subpoena Issued to Non-Party Aetna U.S. Healthcare [PDF]
• Aventis Pharmaceuticals, Inc.'s Motion to Compel Production of Documents [PDF]
• Complaint Counsel's First Request for Admissions by Respondents Natural Organics, Inc. and Gerald A. Kessler [PDF]

October 4, 2000

• Pfizer Inc's Application for in Camera Treatment of Certain Confidential Documents [PDF]
• Bayer Corporation's Motion for In Camera Treatment of Certain Confidential Documents Produced to Respondent Aventis Pharmaceuticals, Inc. [PDF]
• Aventis Pharmaceuticals, Inc.'s Motion to Enforce Compliance with the Subpoena Served on Zenith Goldline Pharmaceuticals, Inc. [PDF]
• Aventis Pharmaceuticals, Inc.'s Motion to Enforce Compliance with the Subpoena Served on Sitrick & Company [PDF]
• Aventis Pharmaceuticals, Inc.'s Motion to Enforce Compliance with the Subpoena Served on Alpharma, Inc. [PDF]
• Order on Schering-Plough's Motion to Quash and Upsher-Smith's Motion to Quash [PDF]

October 3, 2000

• Order on Motions to Quash Subpoenas Served by Anrx on Outside Counsel for Biovail [PDF]

October 2, 2000

• Respondent Andrx Corporation's Application for In Camera Protection of Certain of its Confidential Materials [PDF]
• Order Granting Motions by United States Food and Drug Administration to Quash Subpoenas Served by Aventis Pharmaceuticals, Inc. and Anrx Corporation [PDF]

September 29, 2000

• Respondent Aventis Pharmaceuticals, Inc.'s Application for In Camera Treatment of Certain Confidential Documents [PDF]
• Respondent Carderm Capital L.P.'s Application for In Camera Treatment of Certain Confidential Documents [PDF]
• Non-Party Witness Aetna U.S. Healthcare, Inc.'s Memorandum in Opposition to Aventis Pharmaceuticals, Inc's Motion to Enforce Compliance with the Subpoena Issued to Non-Party Aetna U.S. Healthcare, Inc. [PDF]
• Notice of Apearance (Teresa A. Gonsalves) [PDF]

September 28, 2000

• Order Denying Motion to Amend, Modify and Reissue the Portective Order Governing Dicovery Materials [PDF]
• Complaint Counsel's Motion Regarding Hoechst's Waiver of Attorney-Client Privilege and Motion to Compel Answers to Deposition Questions [PDF]

September 27, 2000

• Non-Party Witness Aetna U.S. Healthcare, Inc.'s Motion for a Protective Order Pursuant to 16 CFR § 3.31(c)(2)&9(d) [PDF]
• Respondent Andrx Corporation's Opposition to joint Motion to Amend, Modify and Reissue the Protective Order [PDF]
• Notice of Apearance (Claudia J. Zuckerman) [PDF]
• Motion of the United States Food and Drug Administration for leave to file a reply memorandum in support of its Motions to Quash Subpoenas Served by Adventis Pharmaceuticals, Inc., and Andrx Corporation [PDF]
• Schering-Plough Corporation's Request for Oral Hearing on Motion to Quash [PDF]
• Complaint Counsel's Consolidated Response to Respondents' Motions for Protective Order [PDF]

September 25, 2000

• Complaint Counsel's First Request for Admissions to Respondent Hoechst Marion Roussel, Inc. [PDF]
• Complaint Counsel's First Request for Admissions to Respondent Andrx Corporation [PDF]
• Respondent Aventis Pharmaceuticals, Inc.'s First Set of Interrogatories [PDF]
• Aventis Pharmaceuticals, Inc.'s Opposition to Joint Motion to Amend, Modify and Reissue the Protective Order Governing Discovery Materials to be Produced by Non-Parties Kaiser Foundation Health Plan, Inc., Bluecross Blueshield of Michigan, and United Healthcare [PDF]
• Order Rescheduling Status Confrence [PDF]

September 21, 2000

• Aventis Pharmaceuticals, Inc.'s Motion to Enforce Compliance with the Subpoena Served on Aetna U.S. Healthcare, Inc. [PDF]
• Order Granting Respondent Aventis Pharmaceuticals, Inc. Motion for the Issuance of a Subpoena Duces Tecum to the Department of Veterans Affaifs [PDF]
• Order Granting Respondent Aventis Pharmaceuticals, Inc. Motion for the Issuance of a Subpoena Duces Tecum to the Department of Defense [PDF]

September 19, 2000

• Order on Application for In Camera Treatment and Modifying the Scheduling Order [PDF]

September 18, 2000

• Respondent Andrx Corporation's Motion for Protective Order Pecluding Duplicative Depositions [PDF]

September 15, 2000

• Respondent Aventis Pharmaceuticals, Inc. Motion for Protective Order [PDF]
• Respondent Aventis Pharmaceuticals, Inc. Motion for the Issuance of a Subpoena Duces Tecum to the Department of Defense [PDF]
• Respondent Aventis Pharmaceuticals, Inc. Motion for the Issuance of a Subpoena Duces Tecum to the Department of Veterans Affairs [PDF]

September 14, 2000

• Order on Complaint Counsel's Motion to Strike [PDF]
• Respondent Andrx Corporation's Revised Witness List [PDF]
• Respondent Andrx Corporation's "Statement of the Case" Reporting on Various Matters [PDF]
• Aventis Pharmaceuticals, Inc.'s Report on Selttlement Negotiations and Compliance with Discovery [PDF]
• Aventis Pharmaceuticals, Inc.'s Statement of the Case [PDF]

September 13, 2000

• Carderm Capital L.P.'s Statement of the Case and Report on Settlement Negotiations and Compliance with Discovery [PDF]
• Complaint Counsel's Statement of the Case [PDF]

September 12, 2000

• Request for Oral Argument [PDF]
• Notice of Apearance (Timothy Curley) [PDF]
• Notice of Apearance (W. Scott Simmer) [PDF]
• Notice of Apearance (Shawn G. Lisle) [PDF]
• Joint Motion to Amend, Modify and Reissue the Protective Order Governing Discovery Materials to be Produced by Non-Parties Kaiser Foundation Health Plan, Inc., Bluecross Blueshield of Michigan, and United Healthcare and Memorandum in Support Thereof [PDF]

September 11, 2000

• Elan Pharmaceuticals, Inc.'s Motion to Quash Third-Party Subpoenas by Andrx Corporation [PDF]
• Notice of Apearance [PDF]
• Respondent Andrx Corporation's Memorandum in Opposition to the Food and Drug Administration's Motion to Quash [PDF]
• Memorandum in Opposition to the Motion of the Food and Drug Administration's Motion to Quash Subpoena Served by Respondent Aventis Pharmaceuticals, Inc. [PDF]

September 6, 2000

• Respondent Andrx Corporation's Memorandum in Opposition to Upsher-Smith's Motion to Quash Third-Party Subpoenae by Andrx Corporation and in Opposition to Schering-Plough's Motion to Quash [PDF]

August 31, 2000

• Stipulation [PDF]

August 28, 2000

• Motion of the United States Food and Drug Administration to Quash Subpoena Served by Aventis Pharmaceuticals, Inc. [PDF]
• Stipulation [PDF]

August 25, 2000

• Schering-Plough Corporation's Motion to Quash [PDF]

August 23, 2000

• Stipulation [PDF]
• Order on Complaint Counsel's Second Motion to Compel Andrx to Produce Documents [PDF]
• Order on Complaint Counsel's Motion to Compel Andrx to Produce Documents [PDF]

August 18, 2000

• Order on Motions to Compel Discovery from Complaint Counsel Filed by Andrx and by Aventis [PDF]
• Order On Respondent Andrx's Motion to Compel Complaint Counsel to Respond to Interrogatories [PDF]

August 17, 2000

• Notice of Appearance [PDF]
• Order Amending Scheduling Order [PDF]
• Upsher-Smith's Motion to Quash Third-Party Subpoenae by Andrx Corporation [PDF]

August 11, 2000

• Motion of the United States Food and Drug Administration to Quash Subpoena Served by Andrx Corporation [PDF]

August 8, 2000

• Order Granting Respondent Adventis' Motion for the Issuance of a Subpoena Duces Tecum to the Food and Drug Administration [PDF]
• Order Denying Motion by Andrx to Clarify or Reconsider the July 5 Order [PDF]

August 7, 2000

• Second Amended Protective Order Governing Discovery Material [PDF]
• Order Granting Consent Motion to Amend and Reissue Protective Order [PDF]

August 2, 2000

• Respondent Aventis Pharmaceuticals, Inc.'s Third Request for the Production of Documents [PDF]

August 1, 2000

• Complaint Counsel's Memorandum in Opposition to Hoechst's Motion for the Issuance of a Subpoena to the Food and Drug Administration [PDF]
• Notice of Amendment to Aventis Pharmaceuticals, Inc.'s Preliminary Witness List [PDF]

July 31, 2000

• Respondent Andrx Corporation's Memorandum  in Opposition to Complaint Counsel's Second Motion to Compel [PDF]

July 25, 2000

• Andrx Corporation's Opposition to Complaint Counsel's Motion to Compel Andrx to Produce Additional Documents [PDF]
• Respondent Aventis Pharmaceuticals, Inc. Motion for the Issuance of a Subpoena Duces Tecum to the Food and Drug Administration [PDF]

July 24, 2000

• Consent Motion to Amend and Reissue Protective Order Governing Discovery Material [PDF]

July 21, 2000

• Complaint Counsel's Second Motion to Compel Respondent Andrx to Produce Documents [PDF]
• ALJ Approved Stipulation, Re: Andrx's Time to Respond to CSC Motion to Compel [PDF]

July 18, 2000

• Non-Party Proskauer Rose LLP's Memorandum in Opposition to Respondent Andrx Corporation's Motion for Clarification or Reconsideration of the July 5 Order Entered in this Case [PDF]
• Objections and Responses to Complaint Counsel's Third Request for Production of Documents and Things Issued to Hoechst Marion Roussel, Inc. [PDF]

July 14, 2000

• Complaint Counsel's Response to Hoechst's July 10 Motion for Leave [PDF]
• Order Granting Motion of Biovail, Melnyk, and Cancellara to Quash Subpoenas and Denying Motion of Andrx to Preclude [PDF]
• Order Setting Hearing on Motions [PDF]
• Stipulation [PDF]

July 10, 2000

• Motion of Aventis Pharmaceuticals, Inc. for Leave to File Limited Reply to Complaint Counsel's Opposition to Respondents' Motions to Compel [PDF]

July 7, 2000

• Complaint Counsel's Motion to Compel Respondent Andrx to Produce Documents [PDF]

July 6, 2000

• Letter from Carderm Capital L.P. ("Carderm") [PDF]
• Respondent Andrx's Motion for an Order Clarifying or Reconsidering the Court's July 5 Order Concerning the Proskauer Subpoena [PDF]

July 5, 2000

• Order Granting Respondent Andrx's Motion for the Issuance of a Subpoena Duces Tecum to the Food and Drug Administration [PDF]
• Order Granting Motion of Proskauer Rose LLP to Quash Subpoena Served By Andrx Corporation [PDF]

June 30, 2000

• Respondent Andrx Corporation's Memorandum in Opposition to the Motions to Quash the Subpoenas Directed at Biovail's Outside Counsel [PDF]
• Respondent Andrx Corporation's Preliminary Witness List [PDF]
• Aventis Pharmaceuticals, Inc's Preliminary Witness List [PDF]
• Complaint Counsel's Opposition to Andrx's Motion to Deny Biovail's Motion to Quash [PDF]

June 23, 2000

• Supplemental Exhibits to Joint Motion to Quash Subpoenas Served on Various Law Firms and Attorneys [PDF]
• Complaint Counsel's Opposition to Respondents' Motion to Compel [PDF]

June 20, 2000

• Biovail's Motion to Quash Subpoenas [PDF]
• Joint Motion to Quash Subpoenas Served on Various Law Firms and Attorneys [PDF]

June 19, 2000

• Complaint Counsel's Opposition to Andrx's Motion to Compe Interrogatories [PDF]
• Respondent Andrx Corporation's Memorandum in Opposition to Biovail's Motion to Quash Subpoenas Issued by Andrx, or in the Alternative, in Support of Andrx's Cross-Motion to Preclude [PDF]

June 16, 2000

• Aventis Pharmaceuticals, Inc.'s Motion to Compel Discovery [PDF]

June 15, 2000

• Aventis Pharmaceuticals, Inc.'s Motion to Strike Complaint Counsel's Motion for Leave to File Supplemental Reply Memorandum in Support of Motion to Strike Certain Affirmative Defenses [PDF]
• Order [PDF]
• ALJ Approved Joint Stipulation Re: Response to Motions [PDF]
• ALJ Approved Joint Stipulation Re: CSC Time to Respond [PDF]

June 14, 2000

• Motion of Proskauer Rose LLP to Quash Subpoena Served by Andrx Corporation [PDF]

June 12, 2000

• Respondent Andrx's Motion for the Issuance of a Subpoena Duces Tecum to the Food and Drug Administration [PDF]
• Respondent Andrx's Motion to Compel Complaint Counsel to Produce Documents [PDF]
• Complaint Counsels Motion for Leave to File Supplemental Reply Memorandum in Support of Motion to Strike Certain Affirmative Defenses [PDF]
• Complaint Counsel's Memorandum in Opposition to Andrx's May 30th Motion [PDF]

June 9, 2000

• Joint Stipulation Re: Response to Motions [PDF]
• Joint Stipulation Re: CSC Time to Respond [PDF]

June 7, 2000

• Motion of Biovail Corporation, Eugene N. Melnyk and Kenneth C. Cancellara to Quash Subpoenas Issued by Andrx Corporation and Memorandum in Support [PDF]

June 5, 2000

• Respondent Andrx's Motion to Compel Complaint Counsel to Respond to Interrogatories or Preclude [PDF]
• Motion of Respondent Andrx Corporation for Leave to File Annexed "Supplemental Submission in Further Opposition to Complaint Counsel's Motion to Strike Affirmative Defenses" [PDF]

June 1, 2000

• Respondent Carderm Capital, L.P.'s Opposition to Complaint Counsel's Motion for Leave to File a Reply in Support of Motion to Strike Affirmative Defenses [PDF]

May 31, 2000

• Respondent Andrx's Motion for an Order (1) Granting Respondents Access to Documents Available to COmplaint Counsel; (2) Declaring That Complaint Counsel's Disclosure of Infomation to Third Parties Violated Statutory and Regulatory Confidentiality Restrictions and the Protective Order Entered in the Matter; and (3) Prohibiting Complaint Counsel from Further Disclosing Confidential Information to Third Parties [PDF]
• Respondent Andrx Corporation's Opposition to Complaint Counsel's Motion for Leave to File a Reply in Support of Motion to Strike Affirmative Defenses [PDF]
• Aventis Pharmaceuticals, Inc.'s Memorandum in Opposition to Complaint Counsels' Motion for Leave to File Reply in Support of Motion to Strike [PDF]

May 26, 2000

• Stipulation [PDF]

• Complaint Counsels' Motion for Leave to File Reply in Support of Motion to Strike [PDF]

May 22, 2000

• Carderm Capital L.P.'s Memorandum in Opposition to Complaint Counsel's Motion to Strike Certain Affirmative Defenses Set Fourth in Respondents' Answers [PDF]

May 19, 2000

• Opposition of Aventis Pharmaceuticals, Inc. to Complaint Counsel's Motion to Strike Certain Affirmative Defenses Set Forth in Respondents' Answers [PDF]
• Respondent Andrx Corporation's Memorandum in Opposition to Compliant Counsel's Motion to Strike Certain Affirmative Defenses [PDF]

May 17, 2000

• Stipulation [PDF]

May 15, 2000

• Complaint Counsel's Response To Respondent Aventis Pharmaceuticals, Inc's First Request For Admissions [PDF]

May 12, 2000

• Respondent's Second Request For The Production Of Documents [PDF]

May 8, 2000

• Order Amending Protective Order Governing Discovery Material [PDF]
• Motion Of Bayer Corporation For Treatment Of Certain Non-Public Commercial Information As Confidential Discovery Material Under The Protective Order Of April 28, 2000 [PDF]

May 5, 2000

• Respondent Andrx Corporation's Opposition To Complaint Counsel's Motion To Amend Protective Order [PDF]
• Petition Of PhRMA To Amend Protective Order To Cover Materials Produced By Third Parties During Investigation [PDF]
• Notice Of Appearance [PDF]

May 4, 2000

• Complaint Counsel's Amended Initial Disclosures [PDF]

May 3, 2000

• Complaint Counsels' Motion To Amend Protective Order Governing Discovery Material [PDF]

April 28, 2000

• Complaint Counsels' Memorandum In Support of their Motion To Strike Certain Affirmative Defenses Set Forth In Respondents' Answers [PDF]
• Complaint Counsels' Motion To Strike Certain Affirmative Defenses Set Forth In Respondents' Answers [PDF]
• Protective Order Governing Discovery Material [PDF]

April 26, 2000

• Scheduling Order [PDF]

April 25, 2000

• Carderm Capital, L.P.'s Initial Disclosures [PDF]

April 24, 2000

• Respondent's First Request for Admissions [PDF]
• Respondent's First Request for The Production Of Documents [PDF]
• Andrx Corporation's Initial Disclosures [PDF]

April 21,2000

• Carderm Capital L.P.'s Answer To The Complaint [PDF]

April 20, 2000

• Order On Prehearing Conference [PDF]
• Notice Of Appearance [PDF]

April 18, 2000

• Aventis Pharmaceuticals Inc.'s Initial Disclosures [PDF]

April 17, 2000

• Complaint Counsel's Initial Disclosures [PDF]

April 14, 2000

• Notice Of Appearance [PDF]

April 13, 2000

• Notice Of Appearance Filed By Kleinfeld, Kaplan And Becker On Behalf Of Carderm Capital L.P. [PDF]
• Answer Of Andrx Corporation [PDF]

April 10, 2000

• Aventis Pharmaceuticals Inc.'s Answer To The Complaint [PDF]

March 30, 2000

• Notice Of Appearance Filed By Shook, Hardy & Bacon L.L.P. On behalf Of Hoechst Marion Roussel, Inc. [PDF]

March 22, 2000

• Notice Of Appearance Filed By Counsel Supporting The Complaint [PDF]

March 16, 2000

• Order Designating Administrative Law Judge [PDF]
• Administrative Complaint